These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17880273)

  • 1. Dendritic systems in drug delivery applications.
    Jain NK; Asthana A
    Expert Opin Drug Deliv; 2007 Sep; 4(5):495-512. PubMed ID: 17880273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimers in biomedical applications--reflections on the field.
    Svenson S; Tomalia DA
    Adv Drug Deliv Rev; 2005 Dec; 57(15):2106-29. PubMed ID: 16305813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in dendrimer-based nanocarriers.
    Bai S; Thomas C; Rawat A; Ahsan F
    Crit Rev Ther Drug Carrier Syst; 2006; 23(6):437-95. PubMed ID: 17425500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
    Ruiz ME; Gantner ME; Talevi A
    Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendronized Systems for the Delivery of Chemotherapeutics.
    Dockery L; Daniel MC
    Adv Cancer Res; 2018; 139():85-120. PubMed ID: 29941108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic nanoparticles: the next generation of nanocarriers?
    Pearson RM; Sunoqrot S; Hsu HJ; Bae JW; Hong S
    Ther Deliv; 2012 Aug; 3(8):941-59. PubMed ID: 22946429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimers and the development of new complex nanomaterials for biomedical applications.
    Gardikis K; Micha-Screttas M; Demetzos C; Steele BR
    Curr Med Chem; 2012; 19(29):4913-28. PubMed ID: 22963629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendrimers as drug carriers: applications in different routes of drug administration.
    Cheng Y; Xu Z; Ma M; Xu T
    J Pharm Sci; 2008 Jan; 97(1):123-43. PubMed ID: 17721949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical and biomedical potential of surface engineered dendrimers.
    Satija J; Gupta U; Jain NK
    Crit Rev Ther Drug Carrier Syst; 2007; 24(3):257-306. PubMed ID: 17956215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.
    Bugno J; Hsu HJ; Hong S
    J Drug Target; 2015; 23(7-8):642-50. PubMed ID: 26453160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendrimer nanoparticles for ocular drug delivery.
    Kambhampati SP; Kannan RM
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):151-65. PubMed ID: 23410062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendrimer nanohybrid carrier systems: an expanding horizon for targeted drug and gene delivery.
    Kesharwani P; Gothwal A; Iyer AK; Jain K; Chourasia MK; Gupta U
    Drug Discov Today; 2018 Feb; 23(2):300-314. PubMed ID: 28697371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: a concise overview.
    Mignani S; El Kazzouli S; Bousmina M; Majoral JP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1316-30. PubMed ID: 23415951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrimers for Therapeutic Delivery: Compositions, Characterizations, and Current Status.
    Nagpal K; Kumar P; Mohan A; Thakur S
    Crit Rev Ther Drug Carrier Syst; 2019; 36(4):277-304. PubMed ID: 31679189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of major parameters of nanoparticles on their physical and chemical properties and recent application of nanodrug delivery system in targeted chemotherapy.
    Zhang J; Tang H; Liu Z; Chen B
    Int J Nanomedicine; 2017; 12():8483-8493. PubMed ID: 29238188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Pharmaceutical Aspects of Dendrimers for the Delivery of Anticancer Drugs.
    Dubey SK; Salunkhe S; Agrawal M; Kali M; Singhvi G; Tiwari S; Saraf S; Saraf S; Alexander A
    Curr Drug Targets; 2020; 21(6):528-540. PubMed ID: 31670619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendrimers in gene transfection.
    Shcharbin DG; Klajnert B; Bryszewska M
    Biochemistry (Mosc); 2009 Oct; 74(10):1070-9. PubMed ID: 19916919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
    Wijagkanalan W; Kawakami S; Hashida M
    Pharm Res; 2011 Jul; 28(7):1500-19. PubMed ID: 21181549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers toward Translational Nanotherapeutics: Concise Key Step Analysis.
    Mignani S; Shi X; Rodrigues J; Roy R; Muñoz-Fernández Á; Ceña V; Majoral JP
    Bioconjug Chem; 2020 Sep; 31(9):2060-2071. PubMed ID: 32786368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications.
    Kalomiraki M; Thermos K; Chaniotakis NA
    Int J Nanomedicine; 2016; 11():1-12. PubMed ID: 26730187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.